Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

被引:53
|
作者
Beaton, Melanie D. [1 ]
机构
[1] Univ Western Ontario, Dept Med, Div Gastroenterol, London, ON, Canada
关键词
Fibrosis; Hepatic steatosis; Metabolic syndrome; Treatment; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; PLACEBO-CONTROLLED TRIAL; VITAMIN-E; URSODEOXYCHOLIC ACID; HEPATIC STEATOSIS; INSULIN-RESISTANCE; BARIATRIC SURGERY; IRON DEPLETION; METFORMIN;
D O I
10.1155/2012/725468
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
MD Beaton. current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. can J gastroenterol 2012;26(6):353-358. Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease.
引用
收藏
页码:353 / 357
页数:5
相关论文
共 50 条
  • [1] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Sugimoto, Keiichiro
    Inui, Hiroshi
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3777 - 3785
  • [2] Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Hung, Chun Kit
    Bodenheimer, Henry C., Jr.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 175 - +
  • [3] Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status
    Stein, Lance L.
    Dong, Mamie H.
    Loomba, Rohit
    ADVANCES IN THERAPY, 2009, 26 (10) : 893 - 907
  • [4] Review of Treatment Options for Nonalcoholic Fatty Liver Disease
    Corrado, Richele L.
    Torres, Dawn M.
    Harrison, Stephen A.
    MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) : 55 - +
  • [5] Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Spengler, Erin K.
    Loomba, Rohit
    MAYO CLINIC PROCEEDINGS, 2015, 90 (09) : 1233 - 1246
  • [6] Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
    Polyzos, Stergios A.
    Kang, Eun Seok
    Boutari, Chrysoula
    Rhee, Eun-Jung
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 111
  • [7] Current treatment options for nonalcoholic fatty liver disease
    Shetty, Akshay
    Syn, Wing-Kin
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (03) : 168 - 176
  • [8] Nonalcoholic Fatty Liver Disease: Pharmacologic and Surgical Options
    Parikh, Neil
    Ahmad, Jawad
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2011, 40 (03) : 541 - +
  • [9] Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Golabi, Pegah
    Bush, Haley
    Younossi, Zobair M.
    CLINICS IN LIVER DISEASE, 2017, 21 (04) : 739 - 753
  • [10] Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis
    Corey, Kathleen E.
    Rinella, Mary E.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1387 - 1397